Condition
Preimplantation Genetic Testing
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
80%
4 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 3 (3)
P 4 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Enrolling By Invitation1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05326087Phase 3Not Yet RecruitingPrimary
Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A
NCT06175832Phase 4Recruiting
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
NCT04414748Phase 3CompletedPrimary
Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A
NCT05447208Phase 3RecruitingPrimary
Effect of GH on the Blastocyst Euploid Rate in AMA Patients
NCT06722313Not ApplicableEnrolling By Invitation
Optimized PGT-M Strategy for Patients with No Proband
Showing all 5 trials